We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » WHO Recommends Roche’s Actemra, Sanofi’s Kevzara to Treat Severe COVID-19
WHO Recommends Roche’s Actemra, Sanofi’s Kevzara to Treat Severe COVID-19
The World Health Organization (WHO) has recommended the use of interleukin-6 receptor blockers — including Roche’s Actemra (tocilizumab) and Sanofi’s Kevzara (sarilumab) — plus corticosteroids for the treatment of severe COVID-19.